Skip to main content
. 2021 Jun 1;9(6):1196. doi: 10.3390/microorganisms9061196

Figure 1.

Figure 1

Viability assessment of Calu-3 cells grown in the presence of a dose range of IFN λ1 and OS administered alone or in combination. IFN λ1 treatment (A), OS treatment (B), IFN λ1 plus OS co-treatment (C). Cell viability was measured by MTT assay. The % of cell viability was calculated based on an untreated control at 48 h post treatment. The results represent the mean and standard deviation from two independent experiments performed in duplicate. IFN λ1 = human IFN λ1; OS = Oseltamivir.